Oh, it's a fantastic role. I mean, we-- just to give you an example, we're now working with a lab here at Scripps that is headed by John Yates to do a comprehensive study of the proteome, all the proteins and cells, and the changes that are induced in the levels of these proteins by individual oncogenes. And the only way you can do this is by having the entire human genome sequenced. That enables the people who work on mospeck to generate the kind of programs and the kind of software that allows the analysis of the entire human proteome.

Peter K. Vogt works at Scripps Research, La Jolla, California. His fundamental studies on oncogenic avian retroviruses led to the identification of oncogenes in human cells. His work also includes the discovery of MYC, the most important driver in human cancer, and he made pioneering contributions to the understanding of PI3Ks, a family of critical cancer targets.

He is a member of the National Academy of Sciences, the National Academy of Medicine and the American Philosophical Society. Dr. Vogt remains actively engaged in research on the biology and genetics of cancer.